Adverse digestive side effects are possible with semaglutide and the precise processes behind this are currently the subject of ongoing research
Additional E11 codes may be appropriate depending on the patient clinical picture: E11.21 - Type 2 diabetes mellitus with diabetic nephropathy E11.36 - Type 2 diabetes mellitus with diabetic cataract E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.51 - Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene Listing all applicable diabetes complication codes strengthens the medical necessity case and helps justify tirzepatide over less expensive alternatives
Clinical trials (SURPASS programme) have demonstrated that participants achieved significant reductions in HbA1c levels and body weight compared to other diabetes medications and placebo
Do not discontinue the medication without medical guidance, as abrupt cessation could adversely affect your diabetes control or weight management goals
For users with a history of reactions, the before-and-after ice protocol provides the most comprehensive prevention
Monitor with Your Provider: Regular Check Ins and Follow Up Tests Schedule periodic visits while on tirzepatide so your clinician can track weight loss speed, symptoms of hair thinning, and lab values
